Home Healthcare IT Insomnia Treatment Market Size, Trends & Growth Analysis Report 2030

Insomnia Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Drug, Devices), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI2892DR
Last Updated : March 21, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Insomnia Treatment Market Introduction
    2. By Treatment Type
      1. Introduction
        1. Treatment Type By Value
      2. Drug
        1. By Value
      3. Devices
        1. By Value
    3. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Other Distribution Channels
        1. By Value
    1. Introduction
    2. By Treatment Type
      1. Introduction
        1. Treatment Type By Value
      2. Drug
        1. By Value
      3. Devices
        1. By Value
    3. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Other Distribution Channels
        1. By Value
    4. U.S.
      1. By Treatment Type
        1. Introduction
          1. Treatment Type By Value
        2. Drug
          1. By Value
        3. Devices
          1. By Value
      2. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Other Distribution Channels
          1. By Value
    5. Canada
    1. Introduction
    2. By Treatment Type
      1. Introduction
        1. Treatment Type By Value
      2. Drug
        1. By Value
      3. Devices
        1. By Value
    3. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Other Distribution Channels
        1. By Value
    4. U.K.
      1. By Treatment Type
        1. Introduction
          1. Treatment Type By Value
        2. Drug
          1. By Value
        3. Devices
          1. By Value
      2. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Other Distribution Channels
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Treatment Type
      1. Introduction
        1. Treatment Type By Value
      2. Drug
        1. By Value
      3. Devices
        1. By Value
    3. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Other Distribution Channels
        1. By Value
    4. China
      1. By Treatment Type
        1. Introduction
          1. Treatment Type By Value
        2. Drug
          1. By Value
        3. Devices
          1. By Value
      2. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Other Distribution Channels
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Treatment Type
      1. Introduction
        1. Treatment Type By Value
      2. Drug
        1. By Value
      3. Devices
        1. By Value
    3. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Other Distribution Channels
        1. By Value
    4. UAE
      1. By Treatment Type
        1. Introduction
          1. Treatment Type By Value
        2. Drug
          1. By Value
        3. Devices
          1. By Value
      2. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Other Distribution Channels
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Treatment Type
      1. Introduction
        1. Treatment Type By Value
      2. Drug
        1. By Value
      3. Devices
        1. By Value
    3. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Other Distribution Channels
        1. By Value
    4. Brazil
      1. By Treatment Type
        1. Introduction
          1. Treatment Type By Value
        2. Drug
          1. By Value
        3. Devices
          1. By Value
      2. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Other Distribution Channels
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Insomnia Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Merck & Co. Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Ebb Therapeutics
    3. Paratek Pharmaceuticals Inc.
    4. Pfizer Inc.
    5. Sanofi SA
    6. Electromedical Products International Inc.
    7. Takeda Pharmaceutical Company Ltd
    8. Cerêve Inc.
    9. Innovative Neurological Devices
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Global Anthrax Treatment Market Size & Trends The global anthrax treatment market size was valued at USD 422.57 million in 2024 and is projected to grow from USD 453.15 million in 2025 to reach USD 697.82 million by 2033, exhibiting a CAGR of 5.
Buy Now
Global Report
The global scar treatment market size was valued at USD 9,206 million in 2021. It is projected to reach USD 21,007 million by 2030, growing at a CAGR of 9.6% during the forecast period (2022–2030). Factors such as rising number of road acc
Buy Now
Global Report
The global seed treatment market size was valued at USD 8822.18 million in 2022. It is projected to reach USD 26041.42 million by 2031, growing at a CAGR of 12.78% during the forecast period (2023–2031). Seed treatment safeguards plants f
Buy Now
Global Report
The Global Tendonitis Treatment Market was valued at USD 193.03 billion in 2021 and is predicted to reach at USD 257.87 billion by 2030, increasing at a CAGR of 3.27% from 2022 to 2030. When the tendon, which is a flexible but inelastic cord of tiss
Buy Now
Global Report
Global Uveitis Treatment Market Size The global uveitis treatment market size was valued at USD 2.28 billion in 2024 and is expected to grow from USD 2.49 billion in 2025 to reach USD 4.88 billion by 2033, growing at a CAGR of 8.8% du
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :